Soru

Zorluk: OrtaPediatric Hematology and Oncology

A 66-year-old boy is brought to the emergency department by his parents due to a new-onset fever and a mild cough that started earlier today. The patient was diagnosed with acute lymphoblastic leukemia (ALL) 44 months ago and is currently receiving maintenance chemotherapy. His last chemotherapy cycle was 1010 days ago. His temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), pulse is 125/min125/\text{min}, respirations are 24/min24/\text{min}, and blood pressure is 95/60 mmHg95/60 \text{ mmHg}. On physical examination, the child appears pale and mildly lethargic but is easily rousable. Lung auscultation is clear bilaterally without wheezing or crackles. There is a central venous port in the right upper chest with no surrounding erythema or induration.

Laboratory studies show:
Leukocyte count: 800/μL800/\mu\text{L}
- Neutrophils: 15%15\%
- Lymphocytes: 80%80\%
- Monocytes: 5%5\%
Hemoglobin: 9.2 g/dL9.2 \text{ g/dL}
Platelet count: 85,000/μL85,000/\mu\text{L}

Which of the following is the most appropriate next step in the management of this patient?

  1. Obtain blood cultures and immediately initiate empiric broad-spectrum intravenous antibioticsCevap
  2. B
    Withhold systemic antimicrobial therapy until blood and sputum culture sensitivities are finalized
  3. C
    Administer inhaled bronchodilators and oral corticosteroids for an acute reactive airway exacerbation
  4. D
    Initiate immediate intravenous furosemide for suspected chemotherapy-induced acute decompensated heart failure
  5. E
    Administer the live-attenuated intranasal influenza vaccine to prevent worsening respiratory viral illness

Cevap

Obtain blood cultures and immediately initiate empiric broad-spectrum intravenous antibiotics.
The correct step is to immediately obtain blood cultures and start empiric broad-spectrum intravenous antibiotics. This patient has febrile neutropenia, defined as a single oral temperature ≥38.3∘C\ge 38.3^\circ\text{C} (101.0∘F101.0^\circ\text{F}) or a sustained temperature ≥38.0∘C\ge 38.0^\circ\text{C} (100.4∘F100.4^\circ\text{F}) for over 11 hour, accompanied by an absolute neutrophil count (ANC) <500/μL< 500/\mu\text{L}. This patient's ANC is calculated as total WBC multiplied by the percentage of neutrophils (800/μL×0.15=120/μL800/\mu\text{L} \times 0.15 = 120/\mu\text{L}). Because neutropenic patients lack an adequate cellular immune response, typical signs of localized infection (like abscess formation or pulmonary infiltrates) are often absent, and bacterial infections (especially Gram-negative pathogens like *Pseudomonas aeruginosa*) can rapidly progress to fatal septic shock. Therefore, prompt blood cultures followed by immediate anti-pseudomonal beta-lactam therapy (e.g., cefepime, piperacillin-tazobactam, or meropenem) is mandatory.

Adım Adım Çözüm

1
Calculate the Absolute Neutrophil Count (ANC).
ANC = Total WBC ×\times (% Neutrophils + % Bands) = 800×0.15=120/μL800 \times 0.15 = 120/\mu\text{L}.
Determining the ANC is required to identify if the patient has severe neutropenia (defined as ANC <500/μL< 500/\mu\text{L}).
2
Combine the ANC calculation with the patient's vital signs.
The patient has a fever of 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}) and an ANC of 120/μL120/\mu\text{L}.
Fever in the presence of severe neutropenia meets the criteria for febrile neutropenia, which is a life-threatening oncologic emergency.
3
Determine the initial management for febrile neutropenia.
Immediate acquisition of blood cultures followed by the administration of empiric broad-spectrum intravenous antibiotics (e.g., cefepime, meropenem, or piperacillin-tazobactam).
Patients with severe neutropenia lack the inflammatory cells to localize infection, making them highly susceptible to rapid progression to septic shock, particularly from Gram-negative organisms like Pseudomonas aeruginosa.

Anahtar Kavram

Febrile Neutropenia Management
Bu soruyu puanla